2. Shah A.S.V., Stelzle D., Lee K.K., Beck E.J., Alam S., Clifford S. et al. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis. Circulation. 2018; 138(11): 1100–1112. DOI: 10.1161/CIRCULATIONAHA. 117.033369

3. Henning R.J., Greene J.N. The epidemiology, mechanisms, diagnosis and treatment of cardiovascular disease in adult patients with HIV. Am. J. Cardiovasc Dis. 2023; 13(2): 101–21. PMID: 37213313

4. Feinstein M.J., Hsue P.Y., Benjamin L.A., Bloomfield G.S., Currier J.S., Freiberg M.S. et al. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation. 2019; 140(2): e98-e124. DOI: 10.1161/CIR.0000000000000695

5. Sico J.J., Chang C.C., So-Armah K., Justice A.C., Hylek E., Skanderson M. et al. Veterans Aging Cohort Study. HIV status and the risk of ischemic stroke among men. Neurology 2015; 84(19): 1933–40. DOI: 10.1212/WNL.0000000000001560

6. Marcus J.L., Leyden W.A., Chao C.R., Chow F.C., Horberg M.A., Hurley L.B. et al. HIV infection and incidence of ischemic stroke. AIDS 2014; 28(13): 1911–9. DOI: 10.1097/QAD.0000000000000352

7. Okeke N.L., Hicks C.B., McKellar M.S., Fowler V.G. Jr, Federspiel J.J. History of AIDS in HIV-infected patients is associated with higher in-hospital mortality following admission for acute myocardial infarction and stroke. J. Infect. Dis. 2016; 213(12): 1955–61. DOI: 10.1093/infdis/jiw082

8. Chow F.C., Bacchetti P., Kim A.S., Price R.W., Hsue P.Y. Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection. AIDS 2014; 28(17): 2573–7. DOI: 10.1097/QAD.0000000000000452

9. Echeverría P., Domingo P., Llibre J.M., Gutierrez M., Mateo G., Puig J., et al. Prevalence of ischemic heart disease and management of coronary risk in daily clinical practice: results from a Mediterranean cohort of HIV-infected patients. Biomed Res Int. 2014; 120(7): 951–9. DOI: 10.1155/2014/823058

10. Paisible A.L., Chang C.C., So-Armah K.A., Butt A.A., Leaf D.A., Budoff M. et al. HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction. J. Acquir. Immune Defic. Syndr. 2015; 68(2): 209–16. DOI: 10.1097/QAI.0000000000000419

11. Patel K., Wang J., Jacobson D.L., Lipshultz S.E., Landy D.C., Geffner M.E. et al. Pediatric HIV/AIDS Cohort Study (PHACS). Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus. Circulation 2014; 129(11): 1204–12. DOI: 10.1161/CIRCULATIONAHA.113.001978

12. Hatleberg C.I., Ryom L., El-Sadr W., Smith C., Weber R., Reiss P. et al. Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals. AIDS 2016; 30(10): 1583–96. DOI: 10.1097/QAD.0000000000001076

13. Sherer R., Solomon S., Schechter M., Nachega J.B., Rockstroh J., Zuniga J.M. HIV provider-patient communication regarding cardiovascular risk: results from the AIDS Treatment for Life International Survey. J. Int. Assoc. Provid. AIDS Care 2014; 13: 342–45. DOI: 10.1177/2325957414530473

14. Kelly S.G., Krueger K.M., Grant J.L., Penugonda S., Feinstein M.J., Taiwo B.O. et al. Statin prescribing practices in the comprehensive care for HIV-infected patients. J. Acquir. Immune Defic. Syndr. 2017; 76: e26–9. DOI: 10.1097/QAI.0000000000001454

15. Schade D.S., Obenshain S.S., Ramo B., Eaton R.P. A Feasible, Simple, Cost-Saving Program to End Cardiovascular Disease in the United States. Am. J. Med. 2019; 132(12): 1365–7. DOI: 10.1016/j.amjmed.2019.03.043

16. Покровский В.В., Юрин О.Г., Кравченко А.В., Беляева В.В., Ермак Т.Н., Шахгильдян В.И. и др. Рекомендации по лечению ВИЧ-инфекции и связанных с ней заболеваний, химиопрофилактике заражения ВИЧ. Эпидемиол. инфекц. болезни. Актуал. вопр. 2023; 13(4, приложение). 109 с.

Pokrovsky V.V., Yurin O.G., Kravchenko A.V., Belyaeva V.V,, Ermak T.N., Shakhgildyan V.I. et al. [Recommendations for the treatment of HIV infection and related diseases, chemoprophylaxis of HIV infection]. Epidemiology and infectious diseases. Current items 2023; 13(4, application). 109 р. (In Russ.).

17. ВИЧ-инфекция у взрослых. Клинические рекомендации. Национальная ассоциация специалистов по профилактике, диагностике и лечению ВИЧ-инфекции, Национальная вирусологическая ассоциация, 2020.

[HIV infection in adults. Clinical guidelines]. National Association of Specialists in the Prevention, Diagnosis and Treatment of HIV Infection, National Virological Association, 2020. (In Russ.).

18. Ambrosioni J., Levi L., Alagaratnam J., van Bremen K., Mastrangelo A., Waalewijn H. et al. EACS Governing Board. Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023. HIV Med. 2023; 24(11): 1126–36. DOI: 10.1111/hiv.13542

19. U.S. Department of Health and Human Services, Health Resources and Services Administration, Guide for HIV/AIDS Clinical Care – 2014 Edition. Rockville, MD: U.S. Department of Health and Human Services, 2014.

20. Zhang Y., Liu W., Zhang W., Cheng R., Tan A., Shen S. et al. Association between blood lead levels and hyperlipidemiais: Results from the NHANES (1999-2018). Front Public Health 2022; 115(15): 1218–28. DOI: 10.3389/fpubh.2022.981749

21. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization, 2021.

22. WHO package of essential noncommunicable (PEN) disease interventions for primary health care. Geneva: World Health Organization, 2020.

23. Csenteri O., Jancsó Z., Szöllösi G.J., Andréka P., Vajer P. Differences of cardiovascular risk assessment in clinical practice using SCORE and SCORE2. Open Heart. 2022; 9(2): 2087–94. DOI: 10.1136/openhrt-2022-002087